Foley Partner David Rosen was quoted in an article that appeared in CNNMoney on August 24, 2010 titled “Recall fallout: FDA puts execs on notice.” Rosen discusses increased efforts by the Food and Drug Administration to identify and potentially prosecute executives at companies that have issued a number of recalls due to manufacturing violations. He states that the FDA is developing a tougher compliance attitude because companies are ignoring warnings from the agency, adding that it appears the FDA wants to send a clearer message regarding regulation and compliance.
People
Related News
06 February 2025
In the News
Vanessa Miller Assesses Panama Canal Discourse
Foley & Lardner LLP partner Vanessa Miller commented in SupplyChainBrain article, "The Fight for Control of the Panama Canal," lending important context to the recent headlines over the important waterway.
06 February 2025
In the News
Gregory Husisian Weighs in on Suspension of De Minimis Trade Exemption
Foley & Lardner LLP partner Gregory Husisian offered context on President Trump's recent trade actions on China in The Wall Street Journal article, "Why Trump Is Closing a Trade Exemption for China."
04 February 2025
In the News
Andrew Wronski on Tariff Fluidity – 'Keep on top of the issues'
Foley & Lardner LLP partner Andrew Wronski assessed the evolving shift in U.S. trade policy in the Milwaukee Business Journal article, "Trump tariffs won't disappear — so how should Wisconsin businesses prepare?"